Previous 10 | Next 10 |
49% of S hares V oted, Q uorum N ot E stablished To Hold Annual Meeting Polls Remain Open Stockholders H olding U nvoted Proxies A re S trongly E ncouraged to V ote T he...
Calls for All Shareholders to Vote so Quorum Requirement t o Hold The Meeting is Met LAWRENCEVILLE, N.J., May 27, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based i...
Celsion Corporation (CLSN) Q1 2021 Earnings Conference Call May 14, 2021, 10:00 AM ET Company Participants Kim Golodetz - IR Michael Tardugno - Chairman, CEO and President Jeff Church - CFO Khursheed Anwer - Chief Science Officer Nicholas Borys - Chief Medical Officer Conference Call Particip...
Celsion (CLSN) shares rise more than 4% during premarket trading after the company posted first-quarter results and talked up its cash position, predicting its capital on hand to fund operations into 2024.Reported a quarterly net loss of $5.7M, or ($0.09) per share, compared with a ...
Focus on Immuno-Oncology and Next-Generation Vaccines is Suppor ted with a Strong Balance Sheet Conference Call Begins at 10:00 a.m. Eastern Time Today LAWRENCEVILLE, N.J., May 14, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clin...
Non-Dilutive Funding Strengthens Balance Sheet, Extends Cash Runway Beyond 2024 Sale of an Additional $5.0 Million of State NOLs Expected in Future Years LAWRENCEVILLE, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-sta...
LAWRENCEVILLE, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at 10:00 a.m. EDT on ...
Stealth BioTherapeutics (MITO) +58% after showcases data for Elamipretide.Luokung Technology Corp. (LKCO) +22% on announcing favorable ruling granting preliminary injunction.Nemaura Medical (NMRD) +23% on 200K sugarBEAT sensors order.American Shared Hospital Services (AMS) +28%...
LAWRENCEVILLE, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced that management participated in Alliance Global Partners’ (AGP) Virtual S...
3 Penny Stocks to Watch Under $2 On Robinhood Finding penny stocks on Robinhood is a relatively straightforward process. However, it takes a little bit of know-how to do properly. While most penny stocks tend to trade the same way, we have to consider that Robinhood does not allow a...
News, Short Squeeze, Breakout and More Instantly...
New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage drug development company, today announced ...
110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone LAWRENCEVILLE, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage company focused on DNA-ba...
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24 th An...